Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 4:24 AM ET

Healthcare Equipment and Supplies

Company Overview of Senseonics Holdings, Inc.

Company Overview

Senseonics Holdings, Inc. engages in the design, development, and commercialization of glucose monitoring systems for people with diabetes. The company’s first generation continuous glucose monitoring (CGM) system, Eversense, is designed to measure glucose levels in people with diabetes for a period of up to 90 days. Its CGM system includes a miniaturized sensor that is designed to be implanted into the subcutaneous space of the upper arm to communicate with the transmitter; and to function noninvasively, automatically, and continuously for up to 90 days before replacement. Senseonics Holdings, Inc. was formerly known as Senseonics, Inc. and changed its name to Senseonics Holdings, Inc. in D...

20451 Seneca Meadows Parkway

Germantown, MD 20876

United States

Founded in 1996

40 Employees

Phone:

301-515-7260

Fax:

301-515-0988

Key Executives for Senseonics Holdings, Inc.

Chief Executive Officer, President and Director
Age: 53
Total Annual Compensation: $365.8K
Chief Financial Officer
Age: 61
Total Annual Compensation: $286.7K
Vice President of Operations, Quality and Regulatory
Age: 42
Total Annual Compensation: $223.0K
Vice President of Global Sales and Marketing
Age: 50
Total Annual Compensation: $221.5K
Compensation as of Fiscal Year 2015.

Senseonics Holdings, Inc. Key Developments

Senseonics Holdings, Inc. and Senseonics, Incorporated Enter into Second Amendment to Loan and Security Agreement

On February 4, 2016, Senseonics Holdings, Inc. and Senseonics, Incorporated, entered into a Second Amendment to Loan and Security Agreement with Oxford Finance, LLC, effective as of January 29, 2016. The Amendment, among other things, modifies the amortization schedule of that certain Loan and Security Agreement, by and among Senseonics Holdings, Subsidiary and Oxford, dated July 31, 2014, as amended. The secured notes previously issued pursuant to the Loan Agreement require monthly payments. Pursuant to the Amendment, if Senseonics Holdings receives a CE mark for its continuous glucose monitoring system, Eversense, by March 4, 2016 or Senseonics Holdings receives net cash proceeds of at least $2,500,000 from the sale of equity securities or a convertible note to Energy Capital, LLC by March 4, 2016 and receives a CE mark for Eversense by March 31, 2016 and, each, a ‘CE Mark Approval Event’, the monthly payments will convert to payments of principal and interest, beginning on August 1, 2016, with the principal amount being amortized over the ensuing 36 months. If a CE Mark Approval Event does not occur, the monthly payments will convert to payments of principal and interest beginning on April 1, 2016, with the principal amount being amortized over the ensuing 40 months. In addition, the Amendment extends the amount of time Senseonics Holdings has to borrow up to an additional $5.0 million under the Loan Agreement on the same terms and conditions of the existing Notes. Pursuant to the Amendment, Senseonics Holdings can borrow the additional $5.0 million following a CE Mark Approval Event until the earliest of March 4, 2016, if an Equity Event does not occur by March 4, 2016, March 31, 2016, if an Equity Event occurs by March 4, 2016, 30 days after the Draw Period commences and the occurrence of an Event of Default. Except as modified by the Amendment, all terms and conditions of the Loan Agreement remain in full force and effect.

Senseonics Holdings, Inc. Signs a Collaboration Agreement with Diasend

Senseonics Holdings, Inc. announced that it has signed a collaboration agreement with Diasend that will allow clinical review of patients CGM data from the Eversense® Continuous Glucose Monitoring (CGM) System using the diasend® Clinic and diasend® Personal solutions. Under this agreement, the two companies will work together to enable clinicians and patients to utilize the diasend® solution to review past Eversense CGM data along with insulin pump and activity tracker data. Senseonics is developing Eversense as a reliable, long-term implantable CGM system to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 days, while the diasend solutions allow users to review glucose reports in familiar and unified formats. The companies are collaborating to integrate Eversense CGM system with the diasend® solutions, thereby allowing clinicians and patients to access 90 days of continuous glucose data from a single CGM sensor to aid in optimizing therapy regimens.

ASN Technologies, Inc. will Change its Name to Senseonics Holdings, Inc

Effective December 22, 2015, ASN Technologies, Inc. will change its name to Senseonics Holdings, Inc.

Similar Private Companies By Industry

Company Name Region
InnerPulse, Inc. United States
Encompass Medical Group, LLC United States
TDC Medical, Inc. United States
Physcient, Inc. United States
Applied Medical Resources Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 10, 2015
ASN Technologies, Inc.
Private Placement
August 4, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Senseonics Holdings, Inc., please visit www.senseonics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.